EXPLORATION AND TREATMENT STRATEGIES FOR GASTROINTESTINAL BLEEDING IN VON WILLEBRAND DISEASE OVER A 3-YEAR PERIOD: A RETROSPECTIVE NATIONAL SURVEY FROM THE FRENCH REFERENCE CENTER FOR VWD

被引：0

作者：

Rauch, A. ^{[1
,2
]}

Paris, C. ^{[1
]}

Repesse, Y. ^{[3
]}

Borel-Derlon, A. ^{[3
]}

Rugeri, L. ^{[4
]}

Harroche, A. ^{[5
]}

Ternisien, C. ^{[6
]}

Castet, S. ^{[7
]}

Lebreton, A. ^{[8
]}

Pan-Petesch, B. ^{[9
]}

Volot, F. ^{[10
]}

Clayssens, S. ^{[11
]}

Chamouni, P. ^{[12
]}

Gay, V. ^{[13
]}

Berger, C. ^{[14
]}

Desprez, D. ^{[15
]}

Biron-Andreani, C. ^{[16
]}

Veyradier, A. ^{[17
]}

Goudemand, J. ^{[1
]}

Susen, S. ^{[1
,2
]}

机构：

[1] CHU Lille, Hematol Transfus, Lille, France

[2] Univ Lille, INSERM, Inst Pasteur Lille, U1011,EGID, Lille, France

[3] CHU Caen, Lab Hematol, Caen, France

[4] CHU Lyon, Unite Hemostase Clin, Ctr Reg Traitement Hemophilie, Bron, France

[5] Hop Necker Enfants Malad, AP HP, Paris, France

[6] CHU Nantes, Lab Hematol, Nantes, France

[7] CHU Bordeaux Pellegrin, Bordeaux, France

[8] CHU Clermont Ferrand, Clermont Ferrand, France

[9] CHU Brest, Brest, France

[10] CHU Dijon, Dijon, France

[11] CHU Toulouse, Toulouse, France

[12] CHU Caen, Rouen, France

[13] CH Metropole Savoie Site Chambery, Chambery, France

[14] CHU St Etienne, St Etienne, France

[15] CHU Strasbourg, Strasbourg, France

[16] CHU Montpellier, Montpellier, France

[17] Hop Lariboisiere, GH St Louis Lariboisiere F Widal, AP HP, Lab Hematol, Paris, France

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO-37

引用

页码：22 / 23

页数：2

共 4 条

[1] Distribution of von Willebrand disease (VWD) types in 197 families from the French national reference center for VWD (CRMW): type 1 is not the most frequent within "true" VWD
Fressinaud, E.
Goudemand, J.
Boisseau, P.
Ternisien, C.
Itzhar, N.
Dreyfus, M.
[J]. HAEMOPHILIA, 2010, 16 : 147 - 147
[2] Distribution of von Willebrand disease (VWD) types in 94 families from the French National Reference Center for VWD (CRMW) : type 1 is not the most frequent within 'true' VWD
Goudemand, J.
Fressinaud, E.
Boisseau, P.
Ternisien, C.
Caron, C.
Trossaert, M.
Itzhar, N.
Borel-Derlon, A.
Dreyfus, M.
Boyer-Neumann, C.
Lambert, T.
Proulle, V
Zawadzki, C.
Meyer, D.
Veyradier, A.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1142 - 1142
[3] Analysis of joint bleeding events from a phase 3, multicenter, open-label study of on-demand recombinant von Willebrand factor (VWF) treatment in patients with severe von Willebrand disease (VWD)
Windyga, J.
Chojnowski, K.
Pasi, J.
Ploder, B.
Mital, A.
Berthoz, F. Truong
Ewenstein, B.
Mellgard, B.
[J]. HAEMOPHILIA, 2019, 25 : 112 - 113
[4] Disease Progression, Treatment Patterns, and Outcomes in Schizophrenia Over a 3-Year Period: Results from the Cohort for the General Study of Schizophrenia (CGS)
Jalbert, Jessica J.
Rossignol, Michel
Rouillon, Frederic
Astruc, Bernard
David, Benoit
Benichou, Jacques
Abenhaim, Lucien
Grimaldi-Bensouda, Lamiae
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 90 - 91

← 1 →